SomaLogic, Inc. Warrant
SLGCW
SLGCW was delisted on the 5th of January, 2024.
1 hedge funds and large institutions have $0 invested in SomaLogic, Inc. Warrant in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
75% less funds holding
Funds holding: 4 → 1 (-3)
100% less capital invested
Capital invested by funds: $11K → $0 (-$11K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
Gagnon Advisors
New York
|
-$9.23K |
| 2 |
GS
Gagnon Securities
New York
|
-$1.4K |
SLGCW Hedge Fund Activity: Q2 2024 in Review
1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in SomaLogic, Inc. Warrant (SLGCW) for Q2 2024, worth a combined $0 — down 100% from $11K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SLGCW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Gagnon Advisors, exiting entirely with an estimated $9.23K sold.
- 1 institutional investor held SomaLogic, Inc. Warrant (SLGCW) as of Q2 2024, down from 4 in Q1 2024.
- Funds reported $0 of SomaLogic, Inc. Warrant stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new SomaLogic, Inc. Warrant positions in Q2 2024 and 3 closed out, a net change of -3 holders.
- The largest SomaLogic, Inc. Warrant seller in Q2 2024 was Gagnon Advisors, an estimated $9.23K sold.
Based on aggregated 13F filings for Q2 2024.